US: Pharmacy's other drugs may be causing illness

October 15, 2012 by Mike Stobbe

Two more drugs from a specialty pharmacy linked to a meningitis outbreak are now being investigated, U.S. health officials said, as they urged doctors to contact patients who got any kind of injection from the company.

The New England Compounding Center of Framingham, Massachusetts, has been under scrutiny since last month, when a rare fungal form of meningitis was linked to its steroid shots used mostly for back pain.

Monday's step by the Food and Drug Administration followed two developments. One was a report of a meningitis illness in a patient who got another type of steroid made by the company.

The agency also learned of two heart transplant patients who got fungal infections after being given a third product from the company during surgery.

The illnesses are under investigation, and it's very possible the heart patients were infected by another source, FDA officials cautioned. They did not say whether fungal meningitis was involved in the new report.

The current outbreak has sickened 214 people, including 15 who have died. For weeks, officials have been urging doctors to contact patients who got shots of the company's steroid methylprednisolone acetate, advise them about the risks of fungal infection, and urge them to take any meningitis symptoms seriously.

The steroid was recalled last month, and the company later shut down operations and recalled all the medicines it makes.

The FDA on Monday expanded its advice to doctors to contact all patients who got any injection made by the company, including steroids and drugs used in eye surgery as well as heart operations. The agency said it took the step "out of an abundance of caution" as it investigates the new reports involving the heart surgery drug and the second steroid, called triamcinolone acetonide.

Last week, federal health officials said 12,000 of the roughly 14,000 people who received steroid shots had been contacted. Nearly all the 214 illnesses are fungal meningitis; two people had joint infections.

Symptoms of meningitis include severe headache, nausea, dizziness and fever. The Centers for Disease Control said many of the cases have been mild, and some people had strokes. Symptoms have been appearing between one and four weeks after patients got the shots, but CDC officials on Thursday warned at least one illness occurred 42 days after a shot.

Explore further: Steroid-related meningitis cases rise to 105

More information: New FDA advisory: www.fda.gov/Drugs/DrugSafety/UCM322734.htm

Outbreak update: www.cdc.gov/HAI/outbreaks/meningitis.html

shares

Related Stories

Steroid-related meningitis cases rise to 105

October 8, 2012
(AP)—Health officials say the number of people sickened by a deadly meningitis outbreak has now reached 105 cases.

US pharmacy linked to outbreak issues wide recall

October 7, 2012
(AP)—The pharmacy that distributed a steroid linked to an outbreak of fungal meningitis has issued a voluntary recall of all of its products, calling the move a precautionary measure.

CDC: Meningitis outbreak death toll rises to 7

October 6, 2012
(AP)—Health officials say the death toll in a rare fungal meningitis outbreak across several states has risen to seven.

Meningitis outbreak toll: 119 cases, 11 deaths

October 9, 2012
(AP)—The number of people sickened by a deadly meningitis outbreak has now reached 119 cases, including 11 deaths.

US warns meningitis cases could rise

October 12, 2012
US authorities have managed to contact most of the thousands of people exposed to the tainted drug blamed for a meningitis outbreak that has killed 14, but warned the number of infections could rise.

US: Avoid drugs from company tied to meningitis (Update)

October 4, 2012
U.S. health officials ramped up warnings Thursday about a specialty pharmacy linked to a widening outbreak of a rare kind of meningitis, urging doctors and hospitals not to use any products from the company.

Recommended for you

Researchers report new system to study chronic hepatitis B

July 25, 2017
Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections. ...

Research examines lung cell turnover as risk factor and target for treatment of influenza pneumonia

July 24, 2017
Influenza is a recurring global health threat that, according to the World Health Organization, is responsible for as many as 500,000 deaths every year, most due to influenza pneumonia, or viral pneumonia. Infection with ...

Scientists propose novel therapy to lessen risk of obesity-linked disease

July 24, 2017
With obesity related illnesses a global pandemic, researchers propose in the Journal of Clinical Investigation using a blood thinner to target molecular drivers of chronic metabolic inflammation in people eating high-fat ...

Raccoon roundworm—a hidden human parasite?

July 24, 2017
The raccoon that topples your trashcan and pillages your garden may leave more than just a mess. More likely than not, it also contaminates your yard with parasites—most notably, raccoon roundworms (Baylisascaris procyonis).

Google searches can be used to track dengue in underdeveloped countries

July 20, 2017
An analytical tool that combines Google search data with government-provided clinical data can quickly and accurately track dengue fever in less-developed countries, according to new research published in PLOS Computational ...

MRSA emerged years before methicillin was even discovered

July 19, 2017
Methicillin resistant Staphylococcus aureus (MRSA) emerged long before the introduction of the antibiotic methicillin into clinical practice, according to a study published in the open access journal Genome Biology. It was ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.